Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | FEN1 | P39748 | 1/20 | 0.35 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 6/20 | 0.32 |
| ▸ | PDE4A | P27815 | 5/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | GPR3 | P46089 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
| ▸ | PTGIR | P43119 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22139297 | 0.99 | ALDH1A1 (0.38) | ALDH1A1TSHRCYP2C19ACHEFEN1 | |
| SCHEMBL13172890 | 0.95 | ALDH1A1 (0.34) | ALDH1A1TSHRCYP2C19ACHEFEN1 | |
| SCHEMBL21453977 | 0.89 | ALDH1A1 (0.36) | ALDH1A1TSHRCYP2C19ACHEFEN1 | |
| SCHEMBL21453980 | 0.89 | ALDH1A1 (0.36) | ALDH1A1TSHRCYP2C19ACHEFEN1 | |
| SCHEMBL13172892 | 0.88 | ALDH1A1 (0.34) | ALDH1A1TSHRCYP2C19ACHEFEN1 | |
| SCHEMBL17706384 | 0.87 | DDB1 (0.36) | ALDH1A1TSHRCYP2C19PDE4BPDE4D | |
| SCHEMBL804985 | 0.87 | L3MBTL1 (0.43) | ALDH1A1PIM3KDM4EATML3MBTL1 | |
| SCHEMBL15855180 | 0.87 | L3MBTL1 (0.43) | ALDH1A1PIM3KDM4EATML3MBTL1 | |
| SCHEMBL126318 | 0.87 | L3MBTL1 (0.43) | ALDH1A1PIM3KDM4EATML3MBTL1 | |
| SCHEMBL23626872 | 0.86 | ACHE (0.33) | ALDH1A1TSHRCYP2C19ACHEFEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8471008-B2 | Material for organic electroluminescent element and organic electroluminescent element employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2013-06-25 | — | — | US | disclosed |
| US-8471008-B2 | Material for organic electroluminescent element and organic electroluminescent element employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2013-06-25 | — | — | US | disclosed |
| US-20120068164-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-03-22 | — | — | US | disclosed |
| US-20120068164-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2012-03-22 | — | — | US | disclosed |
| US-8080658-B2 | Material for organic electroluminescent element and organic electroluminescent element employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-12-20 | — | — | US | disclosed |
| US-8080658-B2 | Material for organic electroluminescent element and organic electroluminescent element employing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-12-20 | — | — | US | disclosed |
| US-7968213-B2 | Material for organic electroluminescence device and organic electroluminescence device utilizing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-06-28 | — | — | US | disclosed |
| US-7968213-B2 | Material for organic electroluminescence device and organic electroluminescence device utilizing the same | IDEMITSU KOSAN CO., LTD. (JP) | 2011-06-28 | — | — | US | disclosed |
| US-20100295027-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-11-25 | — | — | US | disclosed |
| US-20100295027-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | IDEMITSU KOSAN CO., LTD. (JP) | 2010-11-25 | — | — | US | disclosed |
| US-20090030202-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-01-29 | — | — | US | disclosed |
| US-20090030202-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-01-29 | — | — | US | disclosed |
| US-20090017331-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE UTILIZING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-01-15 | — | — | US | disclosed |
| US-20090017331-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE UTILIZING THE SAME | IDEMITSU KOSAN CO., LTD. (JP) | 2009-01-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120068164-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | EMC2, L1CAM, EMC1 | ALDH1A1 2798/4885TSHR 4737/4885CYP2C19 2445/4885 |
| US-20090030202-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT EMPLOYING THE SAME | EMC2, L1CAM, EMC1 | ALDH1A1 2798/4885TSHR 4737/4885CYP2C19 2445/4885 |
| US-20090017331-A1 | MATERIAL FOR ORGANIC ELECTROLUMINESCENCE DEVICE AND ORGANIC ELECTROLUMINESCENCE DEVICE UTILIZING THE SAME | ICMT, ORAI2, ILK | ALDH1A1 2264/4885TSHR 4786/4885CYP2C19 2135/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.